{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:09:52Z","timestamp":1752282592239,"version":"3.41.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofcardiologycases.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology Cases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jccase.2025.02.006","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T21:03:27Z","timestamp":1740603807000},"page":"158-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe cibenzoline toxicity in hypertrophic obstructive cardiomyopathy successfully managed with extracorporeal membrane oxygenation and percutaneous transluminal septal myocardial ablation \u2014 A case report"],"prefix":"10.1016","volume":"31","author":[{"given":"Hiroto","family":"Yagasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Warita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jccase.2025.02.006_bb0005","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jccase.2025.02.006_bb0010","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1253\/circj.CJ-20-0910","article-title":"JCS\/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies","volume":"85","author":"Kitaoka","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jccase.2025.02.006_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jjcc.2015.05.014","article-title":"Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy","volume":"67","author":"Hamada","year":"2016","journal-title":"J Cardiol"},{"key":"10.1016\/j.jccase.2025.02.006_bb0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00007691-200208000-00005","article-title":"Extremely prolonged elimination of cibenzoline at toxic plasma concentrations in patients with renal impairments","volume":"24","author":"Takahashi","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jccase.2025.02.006_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/ams2.507","article-title":"Usefulness of venoarterial extracorporeal membranous oxygenation for fatal cibenzoline succinate poisoning","volume":"7","author":"Sato","year":"2020","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.jccase.2025.02.006_bb0030","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1253\/circj.CJ-20-1212","article-title":"JCS\/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias","volume":"86","author":"Ono","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.jccase.2025.02.006_bb0035","first-page":"139","article-title":"Multicenter actual condition survey of renal excretion drugs brought to hospital by inpatients","volume":"1","author":"Shibata","year":"2012","journal-title":"Jpn J Nephrol Pharmacother"},{"key":"10.1016\/j.jccase.2025.02.006_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/CLT-100102443","article-title":"Effect of charcoal hemoperfusion on clearance of cibenzoline succinate (cifenline) poisoning","volume":"37","author":"Aoyama","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.jccase.2025.02.006_bb0045","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.jacc.2018.09.064","article-title":"Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy","volume":"72","author":"Batzner","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jccase.2025.02.006_bb0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamacardio.2023.3342","article-title":"Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 56 results from the VALOR-HCM randomized clinical trial","volume":"8","author":"Desai","year":"2023","journal-title":"JAMA Cardiol"}],"container-title":["Journal of Cardiology Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540925000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540925000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T05:12:36Z","timestamp":1748754756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878540925000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1878540925000155"],"URL":"https:\/\/doi.org\/10.1016\/j.jccase.2025.02.006","relation":{},"ISSN":["1878-5409"],"issn-type":[{"type":"print","value":"1878-5409"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe cibenzoline toxicity in hypertrophic obstructive cardiomyopathy successfully managed with extracorporeal membrane oxygenation and percutaneous transluminal septal myocardial ablation \u2014 A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology Cases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jccase.2025.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}